Premium Nahrungsergänzungsmittel | artgerecht

Metamyelocyte – Definition and Significance in Blood Tests

A metamyelocyte is an immature precursor cell of granulocytes, a type of white blood cell, produced in the bone marrow. Its presence in peripheral blood may indicate infection, inflammation, or blood disorders.

Regular tips about health Regular tips about health

Things worth knowing about "Metamyelocyte"

A metamyelocyte is an immature precursor cell of granulocytes, a type of white blood cell, produced in the bone marrow. Its presence in peripheral blood may indicate infection, inflammation, or blood disorders.

What is a Metamyelocyte?

A metamyelocyte is an intermediate stage in the maturation of granulocytes – a subgroup of white blood cells (leukocytes) that play a key role in the immune defense against infections. Metamyelocytes are produced in the bone marrow and are not normally found in the peripheral (circulating) blood.

Granulocyte Development Stages

The maturation of granulocytes proceeds through several defined stages:

Myeloblast (earliest precursor cell)
Promyelocyte
Myelocyte
Metamyelocyte
Band cell (stab cell) (also: band neutrophil)
Segmented granulocyte (fully mature, functional white blood cell)

The metamyelocyte is therefore close to full maturity. It is characterized by a kidney-shaped or horseshoe-shaped nucleus that has not yet segmented.

Significance in Blood Count Analysis

Under normal conditions, metamyelocytes remain in the bone marrow and are only released into the bloodstream once fully mature. When metamyelocytes are detected in a peripheral blood smear, this is referred to as a left shift of the blood count. This indicates that the bone marrow is releasing immature cells prematurely into the circulation.

Causes of Metamyelocytes in Peripheral Blood

The appearance of metamyelocytes in a blood count can indicate various conditions:

Bacterial infections (e.g., pneumonia, sepsis): The body requires additional immune cells rapidly and releases immature cells.
Inflammatory conditions: Severe systemic inflammation can trigger a left shift.
Leukemias: Particularly Chronic Myeloid Leukemia (CML) is typically associated with large numbers of metamyelocytes and other precursor cells in the blood.
Myelodysplastic syndromes (MDS): Bone marrow disorders in which normal blood cell production is disrupted.
Reactive processes: Extreme physical exertion, severe burns, or significant tissue damage.

Diagnosis and Clinical Relevance

Metamyelocytes are identified through a differential blood count, in which the various types of white blood cells are counted and assessed either microscopically or using automated analyzers. Additional investigations such as a bone marrow biopsy, inflammatory markers (e.g., CRP, procalcitonin), or molecular genetic testing may be used to determine the underlying cause.

The presence of metamyelocytes in the blood is not a disease in itself, but rather a diagnostic finding that must always be interpreted within the broader clinical context. Early medical evaluation is recommended.

References

Hoffbrand, A.V., Moss, P.A.H. – Essential Haematology. Wiley-Blackwell, 2016.
World Health Organization (WHO) – Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2022.
Kaushansky, K. et al. – Williams Hematology, 9th edition. McGraw-Hill Education, 2016.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.